跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KAFTRIO 75 MG/50 MG/100 MG GRANULADO EN SOBRE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
KAFTRIO 75 MG/50 MG/100 MG GRANULADO EN SOBRE
Approved
STANDARD
KAFTRIO 75 MG/50 MG/100 MG GRANULADO EN SOBRE
Vertex Pharmaceuticals (Ireland) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 14, 2023
Approval ID
e1f466a60763e460
Company
Vertex Pharmaceuticals (Ireland) Limited
Type
Standard
Approval Details
Approval Id
e1f466a60763e460
Drug Cima Aemps Name
KAFTRIO 75 MG/50 MG/100 MG GRANULADO EN SOBRE
Register Number
1201468004
Holder Company Name
Vertex Pharmaceuticals (Ireland) Limited
Marketing Company Name
Vertex Pharmaceuticals (Spain) S.L.
Holder Company Detail Path
/organization/vertex-pharmaceuticals-ireland-limited
Authorization Date
2023-12-14
Dosage Form
GRANULADO EN SOBRE
Dose
75 MG/50 MG/100 MG
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Vertex Pharmaceuticals (Ireland) Limited
Company Detail Path
/organization/vertex-pharmaceuticals-ireland-limited
Company Information
Pharmaceutical Company Name
VERTEX PHARMACEUTICALS (IRELAND) LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
Unit F2, 49 Block
Active Ingredients
IVACAFTOR
75 mg
TEZACAFTOR
50 mg
ELEXACAFTOR
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 14, 2023
Approval ID
e1f466a60763e460
Type
Standard
Back to CIMA-AEMPS Approvals